US Stock MarketDetailed Quotes

ESLA Estrella Immunopharma

Watchlist
  • 0.762
  • +0.022+2.91%
Close Nov 11 16:00 ET
  • 0.762
  • 0.0000.00%
Post 20:01 ET
27.56MMarket Cap-3788P/E (TTM)

About Estrella Immunopharma Company

Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.

Company Profile

SymbolESLA
Company NameEstrella Immunopharma
Listing DateSep 14, 2021
Founded2022
CEODr. Cheng Liu, PhD
MarketNASDAQ
Fiscal Year Ends06-30
Address5858 Horton Street,Suite 370
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-318-9098
Websitehttp://www.estrellabio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Cheng Liu, PhD
  • Chief Executive Officer, President and Director
  • --
  • Jiandong Xu
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Qian Yang
  • Chief Operating Officer
  • --
  • Hong Zhang
  • Chairman of the Board
  • --
  • Xuejun Janelle Wu
  • Independent Director
  • --
  • Pei Xu
  • Independent Director
  • --
  • Fan Wu
  • Independent Director
  • --
  • Dr. Marsha Roberts
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data